Metraipolis › archive › dc_a587396eba31

Mechanistic insights and molecular therapy for neuroendocrine prostate cancer — Europe PMC PMID:42100391

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42100391
DOI
10.3389/fonc.2026.1806742
License (as archived)
solo-consultazione
Archived
2026-11-03T07:46:38.577Z
SHA-256 of the archived text
916593d4e60ebf8ee856ee29b5223c1633da2f83120cb582d2ce785f540b3b87
Stable URL of this page
https://metraipolis.com/documento/dc_a587396eba31

How to cite

Mechanistic insights and molecular therapy for neuroendocrine prostate cancer — Europe PMC PMID:42100391 — Europe PMC (en), https://europepmc.org/article/MED/42100391 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a587396eba31 (Metraipolis archive dc_a587396eba31, sha256 916593d4e60ebf8ee856ee29b5223c1633da2f83120cb582d2ce785f540b3b87)
BibTeX
@misc{dca587396eba31,
  title = {Mechanistic insights and molecular therapy for neuroendocrine prostate cancer — Europe PMC PMID:42100391},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42100391},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a587396eba31; sha256 916593d4e60ebf8ee856ee29b5223c1633da2f83120cb582d2ce785f540b3b87},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42100391. Agents can read the archived copy with the MCP tool read_document.